GSK Investigating Corruption Allegations In UAE
GlaxoSmithKline PLC said Tuesday that it is investigating corruption allegations involving employees in the United Arab Emirates, a month after it was fined a record $488.5 million by a Chinese court...To view the full article, register now.
Already a subscriber? Click here to view full article